Research News – May and June 2018
Catch up on the latest research news!
Research News – May and June 2018 Read More »
SCAs
FDA Orphan Drug Designation for Spinocerebellar
IntraBio, a U.K. based biopharmaceutical company, has received an Orphan Drug Designation from the US Food and Drug Administration (FDA) for its lead compound (IB1000) for the treatment of spinocerebellar
FDA Orphan Drug Designation for Spinocerebellar Read More »
Research News – October and November 2017
Catch up on the Autumn’s latest research news.
Research News – October and November 2017 Read More »
New partnership between Ataxia UK and the Spanish organisations R+SCAs and ACAH
Ataxia UK is working for the first time with the Spanish ataxia patient group R+SCAs (PLATAFORMA DE APOYO A LA INVESTIGACIÓN DE LAS ATAXIAS ESPINOCEREBELOSAS) in funding a research project
New partnership between Ataxia UK and the Spanish organisations R+SCAs and ACAH Read More »
Latest Research News – March and April 2017
Read up on the latest research news!
Latest Research News – March and April 2017 Read More »
Latest Research News – January and February 2017
Read up on the latest research news!
Latest Research News – January and February 2017 Read More »
Latest Research News – December 2016
Read up on the latest research news!
Latest Research News – December 2016 Read More »
European Reference Networks
the European Commission approves the first 23 European Reference Networks for rare diseases (ERNs), including the one covering the ataxias.
European Reference Networks Read More »
Latest Research News – July and August 2016
Read up on the latest research news!
Latest Research News – July and August 2016 Read More »
Latest research news – May and June 2016
Read up on the latest research news!
Latest research news – May and June 2016 Read More »
